文献速递细菌感染、耐药与抗菌药物医院感染防控

艰难梭菌感染相关的特定病因死亡与全因死亡:一项基于人群的队列研究

Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study.
PubMed 文献 · Clin Microbiol Infect · 2023-07-19

该全国性人群队列研究(2006–2019年)纳入43150例艰难梭菌感染(CDI)患者和355172名对照,比较其全因及特定病因死亡。CDI与死亡风险升高相关(与匹配对照相比IRR=3.5,95%CI 3.3-3.6;与瑞典背景人群相比标准化死亡比=6.8,95%CI 6.7-6.9)。医院获得性CDI和首次CDI发作死亡风险最高,且死亡风险升高在调整及分层合并症后仍存在。

要点

  • CDI患者全因死亡风险显著高于匹配对照(IRR=3.5,95%CI 3.3-3.6)。
  • 医院获得性CDI死亡风险最高(IRR=2.4,95%CI 1.9-3.2)。
  • 复发CDI较首次CDI死亡风险更低(IRR=0.2,95%CI 0.2-0.3)。

核心结论

  • CDI与全因及特定病因死亡风险升高相关,尽管可能存在健康状况混杂;死亡风险升高在各性别、各年龄组和各合并症组中一致存在。

研究设计与样本

  • 全国性基于人群的队列研究(2006年至2019年),纳入43150例CDI患者和355172名对照。
  • 采用标准化死亡比与瑞典背景人群比较,并采用1:10匹配队列设计及多变量泊松回归模型计算发病率比(IRR)及95%CI。

主要发现

  • CDI患者与匹配对照相比IRR=3.5(95%CI 3.3-3.6),与瑞典背景人群相比标准化死亡比=6.8(95%CI 6.7-6.9)。
  • 医院获得性CDI的IRR=2.4(95%CI 1.9-3.2)。
  • 复发CDI较首次CDI的IRR=0.2(95%CI 0.2-0.3)。
  • CDI患者慢性合并症多于对照,但调整及分层合并症后CDI患者死亡风险仍更高(IRR=6.1,95%CI 5.5-6.8),尤其在无任何慢性合并症者中。
  • 69.7%为≥65岁,54.9%为女性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出可能存在健康状况混杂(possible confounding by ill health)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Clostridioides difficile infection (CDI) is a common healthcare-associated infection and leading cause of gastroenteritis-related mortality worldwide. However, data on CDI-associated mortality are scarce. We aimed to examine the association between CDI and all-cause and cause-specific mortality. We additionally explored contributing causes of mortality, including recurrent CDI, hospital- or community-acquired CDI, chronic comorbidities, and age. METHODS: This nationwide population-based cohort study (from 2006 to 2019) compared individuals with CDI with the entire Swedish background population using standardized mortality ratios. In addition, a matched-cohort design (1:10), utilizing multivariable Poisson-regression models, provided incidence rate ratios (IRRs) with 95% CIs. RESULTS: This study included 43 150 individuals with CDI and 355 172 controls. In total, 69.7% were ≥65 years, and 54.9% were female. CDI was associated with a 3- to 7-fold increased mortality rate (IRR = 3.5, 95% CI: 3.3-3.6; standardized mortality ratio = 6.8, 95% CI: 6.7-6.9) compared with the matched controls and Swedish background population, respectively. Mortality rates were highest for hospital-acquired CDI (IRR = 2.4, 95% CI: 1.9-3.2) and during the first CDI episode (IRR = 0.2, 95% CI: 0.2-0.3 for recurrent versus first CDI). Individuals with CDI had more chronic comorbidities than controls, yet mortality remained higher among CDI cases even after adjustment and stratification for comorbidity; CDI was associated with increased mortality (IRR = 6.1, 95% CI: 5.5-6.8), particularly among those without any chronic comorbidities. DISCUSSION: CDI was associated with elevated all-cause and cause-specific mortality, despite possible confounding by ill health. Mortality rates were consistently increased across sexes, all age groups, and comorbidity groups.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Boven A, Vlieghe E, Engstrand L, et al. Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study. Clin Microbiol Infect. 2023. PMID: 37473840. doi:10.1016/j.cmi.2023.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。